A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
Frontiers in oncology（2023）
摘要
ClinicalTrials.gov, identifier NCT40155531.
更多查看译文
关键词
breast cancer, radiation dose hypofractionation, toxicity, breast cancer lymphedema, quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要